1326 — Formosa Chemicals & Fibre Balance Sheet
0.000.00%
Last trade - 00:00
- TWD319.36bn
- TWD386.44bn
- TWD332.62bn
- 50
- 42
- 32
- 32
2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 129,287 | 131,622 | 145,371 | 132,863 | 123,950 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 48,674 | 40,259 | 42,546 | 36,972 | 37,086 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 226,183 | 215,865 | 246,631 | 226,085 | 214,906 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 126,316 | 128,811 | 132,475 | 144,512 | 149,851 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 550,549 | 531,820 | 598,345 | 555,546 | 565,870 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 87,133 | 73,453 | 84,917 | 116,951 | 101,226 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 194,034 | 187,467 | 207,375 | 229,420 | 226,612 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 356,515 | 344,354 | 390,971 | 326,127 | 339,259 |
Total Liabilities & Shareholders' Equity | 550,549 | 531,820 | 598,345 | 555,546 | 565,870 |
Total Common Shares Outstanding |